HK1090354A1 - Novel dibenzo [b,f]oxepine-10-carboxamides and pharmaceutical uses thereof - Google Patents

Novel dibenzo [b,f]oxepine-10-carboxamides and pharmaceutical uses thereof

Info

Publication number
HK1090354A1
HK1090354A1 HK06111074.0A HK06111074A HK1090354A1 HK 1090354 A1 HK1090354 A1 HK 1090354A1 HK 06111074 A HK06111074 A HK 06111074A HK 1090354 A1 HK1090354 A1 HK 1090354A1
Authority
HK
Hong Kong
Prior art keywords
oxepine
carboxamides
pharmaceutical uses
novel dibenzo
dibenzo
Prior art date
Application number
HK06111074.0A
Other languages
English (en)
Inventor
Yves Auberson
Claudia Betschart
Stefanie Flohr
Ralf Glatthar
Oliver Simic
Marina Tintelnot-Blomley
Thomas J Troxler
Eric Vangrevelinghe
Siem Jacob Veenstra
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1090354A1 publication Critical patent/HK1090354A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/82Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02Seven-membered rings
    • C07D313/06Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/14[b,f]-condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/30Ortho- or ortho- and peri-condensed systems containing three rings containing seven-membered rings
    • C07C2603/32Dibenzocycloheptenes; Hydrogenated dibenzocycloheptenes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK06111074.0A 2003-07-25 2006-10-09 Novel dibenzo [b,f]oxepine-10-carboxamides and pharmaceutical uses thereof HK1090354A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0317491.9A GB0317491D0 (en) 2003-07-25 2003-07-25 Organic compounds
PCT/EP2004/008283 WO2005014517A2 (en) 2003-07-25 2004-07-23 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof

Publications (1)

Publication Number Publication Date
HK1090354A1 true HK1090354A1 (en) 2006-12-22

Family

ID=27772721

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06111074.0A HK1090354A1 (en) 2003-07-25 2006-10-09 Novel dibenzo [b,f]oxepine-10-carboxamides and pharmaceutical uses thereof

Country Status (16)

Country Link
US (1) US7612054B2 (es)
EP (1) EP1651592B1 (es)
JP (1) JP2006528610A (es)
CN (1) CN100513387C (es)
AT (1) ATE430126T1 (es)
AU (1) AU2004263286B2 (es)
BR (1) BRPI0412928A (es)
CA (1) CA2533174A1 (es)
DE (1) DE602004020896D1 (es)
ES (1) ES2324615T3 (es)
GB (1) GB0317491D0 (es)
HK (1) HK1090354A1 (es)
MX (1) MXPA06000914A (es)
PL (1) PL1651592T3 (es)
PT (1) PT1651592E (es)
WO (1) WO2005014517A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7351738B2 (en) * 2002-11-27 2008-04-01 Elan Pharmaceuticals, Inc. Substituted ureas and carbamates
US20050239836A1 (en) 2004-03-09 2005-10-27 Varghese John Substituted hydroxyethylamine aspartyl protease inhibitors
WO2005087714A2 (en) * 2004-03-09 2005-09-22 Elan Pharmaceuticals, Inc. Methods of treatment of amyloidosis using bi-cyclic aspartyl protease inhibitors
US7385085B2 (en) 2004-07-09 2008-06-10 Elan Pharmaceuticals, Inc. Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
JP2008505929A (ja) * 2004-07-09 2008-02-28 エラン ファーマシューティカルズ,インコーポレイテッド オキシム誘導体ヒドロキシエチルアミン系のアスパラギン酸プロテアーゼ阻害薬
WO2007047305A1 (en) 2005-10-12 2007-04-26 Elan Pharmaceuticals, Inc. Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors
EP1971598A1 (en) * 2005-11-21 2008-09-24 Amgen Inc. Beta-secretase modulators and methods of use
RU2483061C2 (ru) * 2007-07-05 2013-05-27 Шеринг Корпорейшн Тетрагидропиранохроменовые ингибиторы гамма-секретазы

Also Published As

Publication number Publication date
DE602004020896D1 (de) 2009-06-10
EP1651592B1 (en) 2009-04-29
ATE430126T1 (de) 2009-05-15
BRPI0412928A (pt) 2006-09-26
ES2324615T3 (es) 2009-08-11
WO2005014517A3 (en) 2005-04-28
PL1651592T3 (pl) 2009-10-30
JP2006528610A (ja) 2006-12-21
AU2004263286B2 (en) 2009-01-15
AU2004263286A1 (en) 2005-02-17
CN100513387C (zh) 2009-07-15
CA2533174A1 (en) 2005-02-17
WO2005014517A2 (en) 2005-02-17
US20070111991A1 (en) 2007-05-17
CN1823036A (zh) 2006-08-23
MXPA06000914A (es) 2006-03-30
GB0317491D0 (en) 2003-08-27
US7612054B2 (en) 2009-11-03
EP1651592A2 (en) 2006-05-03
PT1651592E (pt) 2009-07-23

Similar Documents

Publication Publication Date Title
MY140693A (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
MY142029A (en) Phenoxyacetic acid derivatives
TW200505837A (en) Novel compounds
HK1090354A1 (en) Novel dibenzo [b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
TW200612892A (en) Novel compounds
MY139303A (en) Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
EP1725536B8 (en) Imidazoline derivatives having cb1-antagonistic activity
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
TW200604196A (en) New quinuclidine derivatives and pharmaceutical compositions comprising them
IL164974A0 (en) Novel compounds and their use
MY136269A (en) Novel diphenylazetidinone, process for its preparation, medicaments comprising this compound and their use
SI1730144T1 (sl) Substituirane spojine 1,4,8-triazaspiro(4.5)dekan-2-on
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
WO2005040171A8 (en) Pyrazolo and imidazo-pyrimidine derivatives
TW200509933A (en) Therapeutic agents
MY146802A (en) Novel drugs for treating respiratory diseases
MXPA05004273A (es) Derivados de fenilalquil y piridilalquil piperazina.
WO2006071564A3 (en) Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents
MXPA05012679A (es) Nuevos derivados de imidazoles, su preparacion y su uso como medicamento.
TW200740440A (en) Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient
IL163608A (en) Sulfonanilides are conserved in their amino / amino acids and derivatives, their process, their pharmaceutical preparations, and their conjugated antibodies and their use in the preparation of drugs for the treatment of culture disorders
TNSN06233A1 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
WO2004069145A3 (en) Anticancer compounds, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130723